Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion

Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease

NCT07151378 ·Status: RECRUITING ·Phase: PHASE3

A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)

NCT02799381 ·Status: COMPLETED ·Phase: PHASE3

Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease

NCT06432309 ·Status: COMPLETED ·Phase: NA

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

NCT00143026 ·Status: COMPLETED ·Phase: PHASE4

Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa

NCT01754129 ·Status: COMPLETED

A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease

NCT01484990 ·Status: COMPLETED ·Phase: PHASE1

eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.

NCT04990284 ·Status: COMPLETED ·Phase: PHASE4

COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel

NCT03362879 ·Status: COMPLETED

Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

NCT06236230 ·Status: RECRUITING ·Phase: PHASE4

A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa

NCT00134966 ·Status: COMPLETED ·Phase: PHASE3

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact

NCT00141518 ·Status: COMPLETED ·Phase: PHASE4

Parkinsonism-Related Oscillations in the Cortico-Basal Ganglia-Thalamic Network During Movement: Beyond the Frequency Range

NCT06438419 ·Status: RECRUITING ·Phase: NA

DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in PD

NCT05579379 ·Status: UNKNOWN

Studying Movement Control in Parkinson's Disease Using Closed Loop Deep Brain Stimulation

NCT02585154 ·Status: COMPLETED ·Phase: NA

Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens

NCT01296464 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of ExAblate Subthalomotomy for the Treatment of Parkinson's Disease Motor Features

NCT03454425 ·Status: COMPLETED ·Phase: NA

Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients

NCT01291537 ·Status: COMPLETED ·Phase: PHASE2

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

NCT00415922 ·Status: COMPLETED ·Phase: PHASE1

A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PD

NCT03964272 ·Status: COMPLETED ·Phase: NA

Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources

NCT01956032 ·Status: COMPLETED

Parkinson's KinetiGraph as Tool for DBS Eligibility Assessment

NCT02509325 ·Status: COMPLETED

ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease

NCT02347254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

One-Year Effect on Levodopa Equivalent Daily Dose of Thalamic VIM Nucleus Stimulation Compared to Subthalamic Nucleus Stimulation in Patients With Parkinson's Disease

NCT06936254 ·Status: NOT_YET_RECRUITING

Parkinson's Disease (PD) Treated With Focused Ultrasound Subthalamotomy at an Early Stage

NCT04692116 ·Status: COMPLETED ·Phase: NA

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers

NCT00415844 ·Status: COMPLETED ·Phase: PHASE1